Akebia Therapeutics, Inc. - 10-Q Filing
Akebia Therapeutics reports Q3 2026 financial results including product revenue and collaboration income.
Tickers: $AKBA
Akebia Therapeutics reports Q3 2026 financial results including product revenue and collaboration income.
Tickers: $AKBA